New PET scan for blood cancers
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a new PET scan method (using a special tracer called 18F-Pentixafor) to see if it can better find and track blood cancers. It may help your doctors get more detailed images with less radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have or are suspected to have a blood cancer (like lymphoma, leukemia, or multiple myeloma).
- Your doctor plans for you to have a standard PET scan or other imaging test as part of your care.
- If your cancer is not yet confirmed, you are willing to have a biopsy to check.
- You are not pregnant or breastfeeding.
- You have not had too much radiation from other tests in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new imaging agent called [68Ga]-FAPI-JNU to take detailed pictures of tumors with a PET/CT scan. It aims to see how well this tracer works in people with various types of cancer.
This trial looks at an imaging scan called CXCR4-targeted PET/CT to help doctors see certain blood cancers. You may be helped by getting clearer information about where cancer is in your body, and the results may guide future care.
This study tests a new imaging method called CXCR4 PET/CT that may help doctors better see and understand lymphomas (a type of blood cancer). It is for people who are newly diagnosed or suspected of having lymphoma and have already had a standard PET/CT.
This early study tests a new PET scan tracer (a radioactive imaging agent) that may light up a cell marker called CXCR4 in certain blood and solid tumor cancers. It may help doctors see where cancers are and how much CXCR4 they have, which could guide future treatments.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This study tests a newer type of PET/MR scan using a special tracer (68Ga-Pentixafor) to see if it can find lymphoma and multiple myeloma lesions better than the standard scan. The scan is painless and takes about 30 minutes, and it might help doctors see the cancer more clearly.
Hear when a new Hematological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.